OK
The material selection platform
Polymer Additives
The material selection platform
Polymer Additives
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

Santoflex™ 6PPD Pastilles

Technical Datasheet | Supplied by Eastman
Santoflex™ 6PPD Pastilles by Eastman is an antioxidant and antiozonant. It provides protection against fatigue degradation in both static and dynamic operating conditions, catalytic degradation by copper and other heavy metals. It gives efficient stabilization for a wide range of solution and emulsion polymers. Due to its specific molecular structure and higher rubber solubility, it is less affected by environmental variables, such as heat or leaching, leading to greater durability. It is compatible with natural and synthetic elastomer compounds. Santoflex™ 6PPD Pastilles is suitable for rubber modification, pneumatic tire components, solid tires, belts, hoses, cables, automotive mounts, bushings and general mechanical products that are exposed to continuous and intermittent dynamic operating conditions and require protection from ozonation. Recommended additive dosage is 1-3 phr.
download
Product Type
  • Other Additives for Rubbers > Antiozonants
  • Antioxidants > Amines
Chemical Composition
No(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine
CAS Number
793-24-8

Compatiblity with other products

Find products that are predicted to be compatible with Santoflex™ 6PPD Pastilles.

This list of compatible products is generated out of estimated HSP values. A practical determination of these HSP values would provide higher certainty.
Learn more about Hansen Solubility Parameters (HSP) and their use in predictive formulation.

Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 55324 Polymer Additives,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top